content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
  <submissionType>144</submissionType>
  <filerInfo>
  <filer>
  <filerCredentials>
  <cik>0001829899</cik>
  <ccc>XXXXXXXX</ccc>
  </filerCredentials>
  </filer>
  <liveTestFlag>LIVE</liveTestFlag>
  </filerInfo>
  </headerData>
  <formData>
  <issuerInfo>
  <issuerCik>0001593899</issuerCik>
  <issuerName>Atea Pharmaceuticals, Inc.</issuerName>
  <secFileNumber>001-39661</secFileNumber>
  <issuerAddress>
  <street1 xmlns="http://www.sec.gov/edgar/common">225 Franklin Street</street1>
  <street2 xmlns="http://www.sec.gov/edgar/common">Suite 2100</street2>
  <city xmlns="http://www.sec.gov/edgar/common">Boston</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">02110</zipCode>
  </issuerAddress>
  <issuerContactPhone>857-284-8891</issuerContactPhone>
  <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Janet MJ Hammond</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
  <relationshipsToIssuer>
  <relationshipToIssuer>Chief Development Officer</relationshipToIssuer>
  </relationshipsToIssuer>
  </issuerInfo>
  <securitiesInformation>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <brokerOrMarketmakerDetails>
  <name>Morgan Stanley</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">2000 Westchester Ave</street1>
  <city xmlns="http://www.sec.gov/edgar/common">Purchase</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">10577-2530</zipCode>
  </address>
  </brokerOrMarketmakerDetails>
  <noOfUnitsSold>16110</noOfUnitsSold>
  <aggregateMarketValue>65567.70</aggregateMarketValue>
  <noOfUnitsOutstanding>83435513</noOfUnitsOutstanding>
  <approxSaleDate>02/01/2024</approxSaleDate>
  <securitiesExchangeName>NASDAQ</securitiesExchangeName>
  </securitiesInformation>
  <securitiesToBeSold>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <acquiredDate>01/31/2024</acquiredDate>
  <natureOfAcquisitionTransaction>Shares acquired upon vesting of restricted stock units awarded under Issuer's 2020 Incentive Award Plan</natureOfAcquisitionTransaction>
  <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
  <isGiftTransaction>N</isGiftTransaction>
  <amountOfSecuritiesAcquired>46800</amountOfSecuritiesAcquired>
  <paymentDate>01/31/2023</paymentDate>
  <natureOfPayment>Services rendered</natureOfPayment>
  </securitiesToBeSold>
  <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
  <noticeSignature>
  <noticeDate>02/01/2024</noticeDate>
  <planAdoptionDates>
  <planAdoptionDate>03/14/2022</planAdoptionDate>
  </planAdoptionDates>
  <signature>/s/ Janet MJ Hammond</signature>
  </noticeSignature>
  </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2925}]
text: 144
  0001829899
  XXXXXXXX
  LIVE
  0001593899
  Atea Pharmaceuticals, Inc.
  001-39661
  225 Franklin Street
  Suite 2100
  Boston
  MA
  02110
  857-284-8891
  Janet MJ Hammond
  Chief Development Officer
  Common Stock
  Morgan Stanley
  2000 Westchester Ave
  Purchase
  NY
  10577-2530
  16110
  65567.70
  83435513
  02/01/2024
  NASDAQ
  Common Stock
  01/31/2024
  Shares acquired upon vesting of restricted stock units awarded under Issuer's 2020 Incentive Award Plan
  Issuer
  N
  46800
  01/31/2023
  Services rendered
  Y
  02/01/2024
  03/14/2022
  /s/ Janet MJ Hammond